Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market 2024 - By Industry Analysis, Future Prediction, Business Overview And Forecast To 2033

The Business Research Company recently released a comprehensive report on the Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=19641&type=smp

According to The Business Research Company's, The percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market size has grown strongly in recent years. It will grow from $1.72 billion in 2023 to $1.83 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to the increasing prevalence of cardiovascular diseases, the aging population, the growing preference for minimally invasive procedures, rising obesity rates, and improved healthcare infrastructure.

The percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market size is expected to see strong growth in the next few years. It will grow to $2.37 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increased emphasis on preventive healthcare, patient preference for shorter hospital stays, favorable reimbursement policies, increasing adoption of drug-eluting balloons, and improved diagnostic techniques. Major trends in the forecast period include technological advancements, expansion into emerging markets, increased patient awareness, customized catheters, and integration with imaging technologies.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/percutaneous-transluminal-coronary-angioplasty-ptca-dilation-catheters-global-market-report

Market Drivers and Trends:

The increase in cardiovascular diseases is expected to propel the growth of the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market going forward. Cardiovascular diseases are rising due to lifestyle factors such as poor diet, lack of exercise, and increased stress, along with an aging global population. Percutaneous transluminal coronary angioplasty dilation catheters are used in cardiovascular diseases to open narrowed or blocked coronary arteries, restoring blood flow to the heart. For instance, in June 2024, the American Heart Association, a US-based public health organization that supports cardiovascular medical research, reported that 45 million adults in the USA are expected to have some form of cardiovascular disease by 2050, up from 28 million in 2020. This projection includes significant increases in hypertension, expected to rise from 51.2% to 61.0%, and obesity, projected to grow from 43.1% to 60.6%. Therefore, the increase in cardiovascular diseases is driving the growth of the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market.

Major companies in the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market are focusing on developing advanced products such as dilation catheters with twin-wall technology to enhance balloon strength and effective artery dilation. Dilation catheters with twin-wall technology are medical devices designed to perform precise and controlled dilation procedures. They feature a unique construction with two concentric layers, or walls, that enhance the catheter's strength, flexibility, and durability. For instance, in February 2023, SIS Medical AG, a Switzerland-based medical device company, launched the OPN NC percutaneous transluminal coronary angioplasty (PTCA) dilatation catheter with Twin-Wall technology in the USA. This catheter offers super high-pressure resistance with a rated burst pressure of 35 atm and low compliance, making it suitable for post-dilatation of under-expanded stents. This unique design provides exceptional pressure resistance and very low compliance, enabling effective treatment of challenging coronary lesions without the risk of over-dilation.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:

Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co Ltd., Merit Medical Systems Inc., Cordis Corporation, MicroPort Scientific Corporation, Biosensors International Group Ltd., Alvimedica Medical Technologies, BrosMed Medical Co Ltd., iVascular SLU, Hexacath, Translumina Therapeutics LLP, Eurocor Tech GmbH, GADA S.p.A., Invamed Group

Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market 2024 Key Insights:

• The percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market size is expected to see strong growth in the next few years. It will grow to $2.37 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%.
• Rising Cardiovascular Disease Prevalence To Drive Growth In Percutaneous Transluminal Coronary Angioplasty Dilation Catheters Market
• Development Of Dilation Catheter With Advanced Pressure Resistance
• North America was the largest region in the percutaneous transluminal coronary angioplasty dilation catheters market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/customise?id=19641&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.